ClinicalTrials.gg
Drug

Clascoterone clinical trials

Also written CB-03-01.

studies test it
25
open now
7
in phase 3
7
first study started
2012

How each study uses Clascoterone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Clascoterone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Aug 2020 · WINLEVI · NDA 213433 (FDA, Drugs@FDA)
European Union
17 Oct 2025 · Winlevi · EMEA/H/C/006138 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

cortexolone 17α-propionate
6
clascoterone (USAN, INN)
4
Winlevi (clascoterone) 1% cream
3
Clascoterone Cream 1%
3
CB-03-01 cream, 1%
3

Brand

WINLEVI
1

Development codes

CB-03-01
3

Studies by the year they started

25 studies that test it; most in 2023 (6)

Studies that test Clascoterone, by start year
YearStudies
20121
20131
20141
20151
20163
20181
20236
20245
20252
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
3
Phase 2
7
Phase 3
7
Phase 4
7
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 6

Cassiopea SpA (7) · Sun Pharmaceutical Industries Limited (6) · Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. (3) · Intrepid Therapeutics, Inc. (3) · Stanford University (1) · Allied Hospital Faisalabad (1) · Khyber Teaching Hospital (1) · Pak Emirates Military Hospital (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Clascoterone.

Studies

Open first, then newest update. How each study uses Clascoterone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test Clascoterone →

Codes

What other systems call Clascoterone · ClinicalTrials.gg INT004741

  • MeSH (NLM) C496269ClascoteroneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) XN7MM8XG2MCLASCOTERONEConfirmed FDA, NLM, Wikidata
  • RxNorm 2474340One source FDA
  • Wikidata Q27293917clascoteroneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169855ClascoteroneOne source FDA
  • DrugBank DB12499One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.